Mexico COFEPRIS Medical Device Registration Mexico Registration Holder (MRH) Consultant
Enter Latin America's second largest medical device market. NexorTest delivers end-to-end COFEPRIS registration Class I/II/III sanitary registration, the new 30 day Equivalency fast track, Third Party (Terceros Autorizados) review, Mexico Registration Holder (MRH) representation, and NOM 241 GMP all under one expert roof.
Three Risk Based Device Classes Under Mexican Health Law
COFEPRIS classifies all medical devices and IVDs by risk based on use, body contact, and permanence. Your class determines the route, documentation, fees, and timeline, with a Class I Low Risk subcategory for the fastest review.
Class I Low Risk
The lowest risk subcategory basic listing with company and device information. Fastest review path with minimal clinical documentation required.
- Fastest Review
- Basic Dossier
- 5 Year Validity
Class I Devices
Low-risk devices such as elastic bandages, crutches, non-powered surgical instruments, and examination gloves. Light documentation burden and quick review.
- Standard / Equivalency
- CFS Required
Class II Devices
Low to moderate risk devices including thermometers, blood pressure monitors, infusion pumps, and many electro medical devices.
- All 3 Routes
- Performance Data
Class III Devices
Highest risk devices such as implantable defibrillators, heart valves, orthopaedic implants, and life supporting devices. Most rigorous technical and clinical review.
- Full Dossier
- Clinical Evidence
Three Routes to Your Registro Sanitario
COFEPRIS offers three pathways to market authorization. Choosing the right one based on your existing approvals and device class can cut months off your timeline.
Equivalency / Abbreviated Route
Leverage an existing approval from a Reference Regulatory Authority FDA, EU CE (MDR/IVDR), Health Canada, Japan PMDA, Swissmedic, TGA, MFDS, ANVISA, or NMPA. Submit a summary dossier under COFEPRIS’s reliance framework. The Mexican market device must be identical to the reference version. Operational since September 2025.
Third Party (Terceros Autorizados) Route
A COFEPRIS authorized third party reviewer pre evaluates your dossier and issues a favourable technical opinion, shortening the official COFEPRIS review. Ideal for Class II/III devices without an eligible RRA approval that still want an accelerated path.
Standard Route
Full technical dossier submitted directly to COFEPRIS for complete review. Required for devices without an eligible reference approval. Timeline scales with class and complexity from a few months for low risk to 18+ months for complex Class III.
Comprehensive Mexico Regulatory Services
From classification and route strategy through post-market Technovigilance, NexorTest manages every aspect of your COFEPRIS registration and Registro Sanitario lifecycle.
COFEPRIS Sanitary Registration
Complete Registro Sanitario for Class I, II, and III medical devices and IVDs. We manage classification, route selection, dossier preparation, the correct COFEPRIS homoclave/submission code, fee payment, and query resolution end to end.
Equivalency 30 Day Fast Track
Abbreviated Regulatory Pathway submissions that leverage your FDA, CE, Health Canada, PMDA, or other RRA approval. We build the summary dossier, demonstrate equivalence, and target COFEPRIS's 30 business day reliance review.
Third-Party Review Coordination
We route eligible Class II/III dossiers through a COFEPRIS authorized Tercero Autorizado for pre-evaluation and a favourable technical report cutting official review time and reducing the risk of deficiency cycles.
Mexico Registration Holder (MRH)
Independent in-country Authorized Representative services. NexorTest holds your Registro Sanitario neutrally, manages all COFEPRIS interactions, and lets you appoint or change distributors freely without losing control of your authorization.
NOM 241 GMP & ISO 13485
Good Manufacturing Practice compliance for Mexico. We map your ISO 13485 or MDSAP system to NOM-241-SSA1, run gap analysis and remediation, and leverage a MDSAP and other recognized QMS evidence may support in GMP compliance assessment, subject to COFEPRIS requirements
Spanish Labeling & NOM-137
Spanish language labeling and Instructions for Use compliant with NOM-137-SSA1 generic name, country of origin, registration number, expiry, and lot/serial. Discrepancy free translations that prevent the most common cause of rejection.
IVD Registration Mexico
In Vitro Diagnostic registration under the Class I/II/III framework, including analytical and clinical performance evidence, reagent documentation, and Equivalency route submissions for IVDs already approved by a reference authority.
SaMD & Digital Health
Software as a Medical Device strategy for Mexico: software lifecycle and validation documentation, cybersecurity risk assessment, AI/ML evidence, and registration aligned with COFEPRIS's evolving digital health expectations.
Technovigilance & Renewals
Post-market Technovigilance (adverse event) reporting, variations management, and registration renewals now valid up to 10 years under the 2026 reform of Article 376. We keep your Registro Sanitario active and compliant throughout its lifecycle.
Mexico's Trusted COFEPRIS Specialist
We combine a bilingual Mexico City regulatory team with reliance and Equivalency expertise to deliver faster, more predictable COFEPRIS registrations and independent MRH representation that keeps you in control.
Bilingual Mexico City Regulatory Team
Spanish native regulatory professionals experienced in COFEPRIS procedures, submission requirements, and regulatory expectations.
Reliance & Equivalency Specialists
We turn your FDA, CE, or Health Canada approval into a qualifying Equivalency submission, targeting COFEPRIS's 30 business day reliance review rather than a multi-month standard evaluation.
Independent MRH You Keep Control
We hold your Registro Sanitario as a neutral Authorized Representative, so you can switch or add distributors anytime without your registration being held hostage by a single commercial partner.
One Partner for USMCA & Global Access
Coordinate Mexico alongside the US FDA, Health Canada, and Brazil ANVISA from a single integrated program turning one dossier into North American and Latin American market access.
Transparent Fixed Fee Packages
Our fixed fee scopes cover strategy, MRH, dossier, submission, and post-market support, with clear milestones and deliverables.
Six Steps to Your Registro Sanitario
A proven, structured approach that minimises COFEPRIS deficiencies and accelerates your path to a Registro Sanitario.
Classification & Route Strategy
We confirm your COFEPRIS risk class (I, II, or III) and select the optimal route Standard, Third Party, or Equivalency based on your existing FDA, CE, Health Canada, or other RRA approvals to minimise time and cost.
Appoint Mexico Registration Holder
NexorTest is appointed as your independent MRH and in-country Authorized Representative. We set up the COFEPRIS company account and prepare all legal authorization documentation.
Dossier Preparation in Spanish
We compile and translate the dossier device description, risk analysis (ISO 14971), GMP/ISO 13485 or MDSAP evidence, clinical/performance data, Certificate of Free Sale, and NOM-137-compliant labeling.
Pre-Submission QC or Third Party Review
We run a deficiency prevention quality check, or route eligible dossiers through a COFEPRIS-authorized Tercero Autorizado for a favourable technical opinion that shortens official review.
COFEPRIS Submission & Query Management
We submit via the correct homoclave/submission code, pay government fees, and manage every technical query and deficiency response to keep the review clock moving toward approval.
Registro Sanitario & Post-Market
You receive your Registro Sanitario. We set up Technovigilance reporting and manage variations and renewals now valid up to 10 years under the 2026 reform.
COFEPRIS Expertise Across Every Device Category
From implantables to digital health, our regulatory specialists cover the full breadth of medical technology entering the Mexican market.
- 🫀 Cardiovascular & Implants
- 🧬 In Vitro Diagnostics
- 💻 SaMD & Digital Health
- 🩻 Imaging & Radiology
- 🦴 Orthopaedics
- 💉 Infusion & Drug Delivery
- 🩸 Surgical Instruments
- 👁 Ophthalmics
- 🦷 Dental Devices
- 🏥 Electro-Medical Equipment
- 📱 Wearables & Remote Monitoring
- 🔬 Laboratory Equipment
Frequently Asked Questions for COFEPRIS Medical Device Registration Mexico
What is COFEPRIS medical device registration in Mexico?
COFEPRIS medical device registration (Registro Sanitario) is the mandatory market authorization issued by the Comisión Federal para la Protección contra Riesgos Sanitarios, the regulator within Mexico’s Ministry of Health (Secretaría de Salud). Under the General Health Law and the Health Supplies Regulations, every medical device and IVD imported into or sold in Mexico must hold a valid Registro Sanitario before commercialization. The process involves classification (Class I, II, or III), appointment of a Mexico Registration Holder (MRH) for foreign manufacturers, dossier preparation, and submission via the Standard, Third-Party, or Equivalency route. Registrations are valid for 5 years, with subsequent renewals of up to 10 years under the January 2026 reform.
What are the COFEPRIS device classification classes?
COFEPRIS uses a three-tier risk-based system adapted from European rules. Class I covers low-risk devices (bandages, crutches, non-powered instruments), with a Class I Low Risk subcategory for the fastest review. Class II covers low-to-moderate risk devices (thermometers, blood pressure monitors, infusion pumps), subdivided into IIa and IIb. Class III covers high-risk devices (implantable defibrillators, heart valves, orthopaedic implants). Classification is based on the device’s use, body contact, and permanence, and determines the route, documentation, fees, and timeline.
What is a Mexico Registration Holder (MRH)?
A Mexico Registration Holder (MRH), also called the in-country Authorized Representative, is a legal entity established in Mexico that holds a foreign manufacturer’s COFEPRIS Registro Sanitario. Appointing an MRH is a legal prerequisite for any manufacturer without a local presence. The MRH submits applications, manages renewals and variations, serves as the official contact with COFEPRIS, and handles Technovigilance reporting. NexorTest provides independent MRH services, holding your registration neutrally so you retain full freedom to appoint or replace distributors without losing control of your authorizations.
What is the Equivalency route and the 30-day fast-track?
The Equivalency route (Abbreviated Regulatory Pathway) lets manufacturers leverage an existing approval from a Reference Regulatory Authority for expedited COFEPRIS authorization. Since September 2025, eligibility expanded beyond FDA, Health Canada, and Japan PMDA to include IMDRF and MDSAP-recognized authorities such as the EU CE (MDR/IVDR), Swissmedic, TGA, MFDS, ANVISA, and NMPA. Manufacturers submit a summary dossier rather than a full technical package, and COFEPRIS targets a review of about 30 business days for complete, qualifying submissions. The Mexican-market device must be identical to the reference version in formulation, manufacturing, intended use, and specifications.
How long does COFEPRIS registration take?
Timelines depend on the route and class. The Equivalency route targets ~30 business days for qualifying devices already approved by a reference authority. The Third-Party (Terceros Autorizados) route typically takes 2–5 months, as an authorized reviewer pre-evaluates the dossier. The Standard route generally runs 3–6 months for lower-risk devices and can extend to 6–18 months for complex Class III, depending on COFEPRIS workload and query cycles. Documentation completeness is the biggest driver; NexorTest’s pre-submission review minimizes deficiency requests that pause the clock.
What documents are required for COFEPRIS registration?
Required documents include: a technical dossier with device description, intended use, and design/manufacturing information; a Certificate of Free Sale (CFS) or Certificate to Foreign Government; ISO 13485, MDSAP, CE Certificate of Conformity, or a GMP certificate as quality-system evidence; risk analysis (ISO 14971); clinical/performance evidence appropriate to the class; Spanish-language labeling and IFU per NOM-137-SSA1; and the MRH authorization letter. Equivalency submissions additionally require the reference authority’s marketing authorization and a Clinical Evaluation Report. NexorTest prepares and quality-checks the full dossier in Spanish before submission.
Is ISO 13485 and NOM-241 GMP mandatory?
ISO 13485 is not strictly mandatory by law, but COFEPRIS expects a robust, audited quality management system in practice — an ISO 13485 certificate, MDSAP audit report, CE marking, or government-issued GMP certificate is the standard expectation. NOM-241-SSA1 is Mexico’s GMP standard for medical devices, and an existing ISO 13485 system satisfies NOM-241 through an established equivalency, so you do not need a parallel Mexican quality system. Because Mexico recognizes MDSAP certificates as GMP evidence, a valid MDSAP certificate can replace a separate Mexican GMP inspection for both the Standard and Equivalency routes. NexorTest provides ISO 13485 and NOM-241 gap analysis and remediation.
What is the cost of COFEPRIS registration?
Costs include government fees, professional fees, and MRH fees. Indicative COFEPRIS government fees run roughly USD 650 (Class I), USD 1,000 (Class II), and USD 1,250 (Class III) per registration, and Third-Party reviewer fees typically add USD 2,000–4,000. Renewal fees, payable per product and risk class, are approximately MXN 12,374 (Class I), MXN 18,149 (Class II), and MXN 23,098 (Class III). Professional fees depend on device complexity, route, and scope including MRH representation. NexorTest offers transparent fixed-fee packages covering strategy, MRH appointment, dossier preparation, submission, and post-market support. Contact us for a free cost assessment.
Ready to Enter the Mexican Medical Device Market?
Get a free COFEPRIS regulatory assessment from specialists in Mexican market access. Our experts will map your fastest route including the 30 day Equivalency fast track to a Registro Sanitario.